Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
力矩中国 (Lever China) is a venture capital fund established in mid-2020, specifically targeting the alternative protein sector in China. As the first dedicated VC fund in this market, Lever China aims to support early-stage companies developing plant-based and cell-cultivated protein products. The fund operates in partnership with Lever VC, a global leader in alternative protein investments, and collaborates with local entities such as Lever Foods and Brinc Accelerator.
Lever China has a total fund size of approximately $6 million (RMB 200 million), with plans to make around 10 investments per year over a four-year horizon, targeting a total of approximately 40 portfolio companies. The fund's headquarters are located in China, with operations primarily in Shanghai and Beijing. Lever China is backed by notable corporate partners, including COFCO VC and Yili Group VC, which enhances its access to industry resources and networks.
Lever China focuses on early-stage investments in the alternative protein sector, specifically targeting companies that produce plant-based and cultivated meat products. The fund's investment strategy is driven by a commitment to support innovative entrepreneurs who are transforming the food landscape in China. Check sizes typically range from $50,000 to $250,000, allowing for flexibility in funding various stages of development.
The fund aims to leverage over 15 years of combined experience in alternative protein investing globally, which includes early investments in companies like Beyond Meat and Impossible Foods. Lever China seeks to back outstanding Chinese entrepreneurs who are building innovative products in the plant-based and cultivated meat categories. The fund operates a dedicated foodtech accelerator program in Guangzhou, further enhancing its support for portfolio companies.
Lever China's portfolio includes five notable companies that are making strides in the alternative protein sector:
These companies represent a diverse range of products within the alternative protein market, showcasing Lever China's commitment to supporting innovation in food technology.
Nick Cooney — Managing Partner at Lever VC, Co-Founder of New Crop Capital and Good Food Institute. He has a strong background in alternative protein investments, having been an early investor in Beyond Meat and Memphis Meats.
Lawrence Chu — Founder & Chairman of BlackPine Private Equity, with over $1.5 billion deployed in VC/PE. He has invested in notable companies such as Impossible Foods and Beyond Meat.
Nina Ju — Investment Director (China) at Lever China, responsible for sourcing and evaluating investment opportunities within the alternative protein sector.
Lily Chen — Program Manager at Lever Foods, overseeing operations in China and supporting portfolio companies through the accelerator program.
Founders interested in pitching to Lever China should prepare a comprehensive pitch deck that includes an overview of their business model, market opportunity, and financial projections. While specific application forms or portals are not publicly available, reaching out through their website or leveraging industry connections may facilitate introductions. Response times can vary, so founders should be prepared for potential follow-up discussions.
Lever China operates a dedicated foodtech accelerator program in Guangzhou, designed to support early-stage companies in the alternative protein sector. This program provides mentorship, operational support, and access to industry networks. Startups interested in participating should demonstrate a strong business model and innovative approach to alternative protein products.
In March 2023, Lever China announced its continued focus on early-stage investments in the alternative protein sector, reaffirming its commitment to support innovative startups. The fund is actively collaborating with Lever VC and local partners to enhance its investment strategy.
As of September 2022, Lever China successfully completed its first cohort of investments, which included companies like HERO Protein and HaoFood, marking a significant milestone in its investment journey.
What are Lever China's investment criteria?
Lever China focuses on early-stage companies in the alternative protein sector, specifically those developing plant-based and cultivated meat products. The fund looks for innovative entrepreneurs with strong business models and the potential for significant market impact.
How can founders apply or pitch to Lever China?
Founders interested in pitching to Lever China should prepare a detailed business plan and financial projections. While specific application channels are not publicly listed, reaching out through their website or leveraging connections within the foodtech community may facilitate introductions.
What makes Lever China different from other VC firms?
Lever China is the first dedicated VC fund in China targeting the alternative protein market. Its partnership with Lever VC and local entities like Lever Foods and Brinc Accelerator provides unique access to industry expertise and resources.
What is the geographic scope of Lever China's investments?
Lever China primarily invests in early-stage companies located in China, focusing on the burgeoning alternative protein sector within the region.
What is the fund size and typical check size?
Lever China has a total fund size of approximately $6 million (RMB 200 million), with check sizes ranging from $50,000 to $250,000 for individual investments.
What kind of post-investment support does Lever China provide?
Lever China offers operational support through its partnership with Lever Foods and access to a robust network of industry partners. The fund also runs a foodtech accelerator program to further assist portfolio companies in their growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.